Patent ID: 8236048

Claim:
A drug delivery device comprising: an intraluminal medical device, the intraluminal medical device including a stent having a fenestrated structure, the stent comprising a plurality of bands and links defining a substantially tubular device with openings; a polymeric coating affixed to the bands and links of the fenestrated structure, the polymeric coating including first and second layers; and a therapeutic dosage of rapamycin incorporated into the polymeric coating for treatment of intimal hyperplasia, constrictive vascular remodeling, and inflammation caused by injury, the rapamycin being incorporated into the first layer of the polymeric coating, the first layer comprising a solution of ethylene-co-vinylacetate and polybutylmethacrylate, and the second layer, comprising polybutylmethacrylate and acting as a diffusion layer, the first layer having a thickness in the range from about eight microns to about twelve microns and the second layer having a thickness in the range from about one micron to about two microns, the rapamycin being configured for release over a period of about seven to thirty days and having a dosage in the range from about 35 to 430 micrograms per 15 to 18 mm length stents thereby producing a peak 50 to 55 percent reduction in neointimal hyperplasia.